Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114276280B reveals enzymatic route for chiral sulfonamide. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles. This method offers significant cost reduction in pharmaceutical intermediate manufacturing via simplified processing.
Discover a novel metal-free synthesis for pyrimidoindazole compounds via patent CN109912606B. Offers cost reduction in API manufacturing and scalable production.
Patent CN106995461B reveals a novel benzofuran phosphine ligand enhancing Suzuki-Miyaura coupling yields up to 99% for efficient pharmaceutical intermediate manufacturing and supply chain stability.
Novel one-pot metal-free halogenation and coupling route for quinoline derivatives. Delivers cost reduction in pharma intermediate manufacturing with high purity.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis. Enables cost reduction and supply chain reliability for anticancer intermediates.
Patent CN107629049B reveals a cost-effective Co/Cu catalyzed route for pyrido[2,1-a]isoindoles, offering reliable supply chain solutions for pharmaceutical intermediates.
Patent CN113307778A details a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate supply.
Patent CN113429349A details a heterogeneous copper-catalyzed route for 2-trifluoromethyl benzimidazoles, offering scalable pharma intermediate production with recyclable catalysts.
Novel chiral phase transfer catalysis enables high-purity indole derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediate supply chains globally.
Patent CN104326892A details gold-catalyzed indanone synthesis offering high yield and green oxidation for reliable pharmaceutical intermediates supplier cost efficiency.
Patent CN114773301A details a mild Rh(III) catalyzed route to furans. This technology offers significant cost reduction in API manufacturing through efficient cyclization.
Patent CN113307790B reveals a metal-free oxidative cyclization for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN116041393B reveals a novel N-N axis chiral ligand offering superior stereoselectivity and cost-effective synthesis for asymmetric catalysis applications.
Patent CN112680497A reveals enzymatic splitting for high-purity Corey lactone. Achieve significant cost reduction in API intermediate manufacturing and supply reliability.
Patent CN107445989B discloses novel indole-based phosphine ligands offering high catalytic activity for C-S bond formation, ensuring cost-effective pharmaceutical intermediate manufacturing.
Patent CN113429349A details a heterogeneous copper-catalyzed route for high-purity benzimidazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel synthesis method for 3,4-dihydropyrano[3,2-b]indol-2-one offers high yield and mild conditions. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Patent CN115925722B details a scalable copper halide method for tazobactam intermediates. This process offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel copper-catalyzed ring-opening allylation of cyclopropanols offers high-yield, green route for pharmaceutical intermediates and complex molecule synthesis.